These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30032361)

  • 1. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Broner EC; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2017 Feb; 60():180-187. PubMed ID: 27825812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.
    Harel-Dassa K; Yedgar S; Tropé CG; Davidson B; Reich R
    Hum Pathol; 2017 Apr; 62():115-121. PubMed ID: 28087476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of the altered expression of lysophosphatidic acid receptors, autotaxin and phospholipase A2 as the potential biomarkers in type 1 endometrial cancer biology.
    Wasniewski T; Woclawek-Potocka I; Boruszewska D; Kowalczyk-Zieba I; Sinderewicz E; Grycmacher K
    Oncol Rep; 2015 Nov; 34(5):2760-7. PubMed ID: 26327335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
    Filippov-Levy N; Cohen-Schussheim H; Tropé CG; Hetland Falkenthal TE; Smith Y; Davidson B; Reich R
    Gynecol Oncol; 2018 Mar; 148(3):559-566. PubMed ID: 29310950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma.
    Davidson B; Holth A; Dong HP
    Virchows Arch; 2020 Nov; 477(5):677-685. PubMed ID: 32472195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
    Davidson B; Holth A; Hellesylt E; Hadar R; Katz B; Tropé CG; Reich R
    Hum Pathol; 2016 Feb; 48():95-101. PubMed ID: 26640230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ splicing and canonical pathway activation in high-grade serous carcinoma.
    Gutgold N; Davidson B; Catane LJ; Holth A; Hellesylt E; Tropé CG; Dørum A; Reich R
    Virchows Arch; 2017 Jun; 470(6):665-678. PubMed ID: 28432432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.
    Nymoen DA; Slipicevic A; Holth A; Emilsen E; Hetland Falkenthal TE; Tropé CG; Reich R; Flørenes VA; Davidson B
    Hum Pathol; 2016 Aug; 54():74-81. PubMed ID: 27063471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.
    Davidson B; Bock AJ; Holth A; Nymoen DA
    Cytopathology; 2020 Nov; 31(6):572-578. PubMed ID: 32741023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
    Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.
    Laface C; Ricci AD; Vallarelli S; Ostuni C; Rizzo A; Ambrogio F; Centonze M; Schirizzi A; De Leonardis G; D'Alessandro R; Lotesoriere C; Giannelli G
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin/Lpar3 signaling regulates Kupffer's vesicle formation and left-right asymmetry in zebrafish.
    Lai SL; Yao WL; Tsao KC; Houben AJ; Albers HM; Ovaa H; Moolenaar WH; Lee SJ
    Development; 2012 Dec; 139(23):4439-48. PubMed ID: 23095890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
    Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
    Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma.
    Chehover M; Reich R; Davidson B
    Virchows Arch; 2020 Aug; 477(2):249-258. PubMed ID: 31900634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.